In March 2025, the company introduced new designs for the direct-to-shopper supplying of its Wegovy weight loss drug. The company founded a fresh pharmacy, identified as NovoCare, which might charge customers $499 per 30 days for use of the drug, lower than 50 percent the price of the drug by other pharmaceutical distribution networks.[fifty three]